These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9777174)

  • 1. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF.
    Atack JR; Schapiro MB
    Neurobiol Aging; 2002; 23(3):389-96. PubMed ID: 11959401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inositol monophosphatase in human cerebrospinal fluid.
    Atack JR; Rapoport SI; Varley CL
    Brain Res; 1993 Jun; 613(2):305-8. PubMed ID: 8186981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.
    Shamir A; Elhadad N; Belmaker RH; Agam G
    Bipolar Disord; 2005 Feb; 7(1):42-8. PubMed ID: 15654931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain inositol monophosphatase identified as a galactose 1-phosphatase.
    Parthasarathy R; Parthasarathy L; Vadnal R
    Brain Res; 1997 Dec; 778(1):99-106. PubMed ID: 9462881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.
    Levi I; Eskira Y; Eisenstein M; Gilon C; Hoffman A; Tal-Gan Y; Fanous J; Bersudsky Y; Belmaker RH; Agam G; Almog O
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1806-15. PubMed ID: 23619164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol monophosphatase inhibitors--lithium mimetics?
    Atack JR
    Med Res Rev; 1997 Mar; 17(2):215-24. PubMed ID: 9057165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of inositol monophosphatase.
    Fauroux CM; Freeman S
    J Enzyme Inhib; 1999; 14(2):97-108. PubMed ID: 10445037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330.
    Kraft L; Roe SM; Gill R; Atack JR
    Acta Crystallogr D Struct Biol; 2018 Oct; 74(Pt 10):973-978. PubMed ID: 30289407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between Ras and inositol phosphate signaling revealed by lithium action on inositol monophosphatase in Schizophyllum commune.
    Murry R; Kniemeyer O; Krause K; Saiardi A; Kothe E
    Adv Biol Regul; 2019 May; 72():78-88. PubMed ID: 30639095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1.
    Ohnishi T; Ohba H; Seo KC; Im J; Sato Y; Iwayama Y; Furuichi T; Chung SK; Yoshikawa T
    J Biol Chem; 2007 Jan; 282(1):637-46. PubMed ID: 17068342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
    Atack JR; Prior AM; Fletcher SR; Quirk K; McKernan R; Ragan CI
    J Pharmacol Exp Ther; 1994 Jul; 270(1):70-6. PubMed ID: 8035344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol monophosphatase, the putative therapeutic target for lithium.
    Atack JR
    Brain Res Brain Res Rev; 1996 Aug; 22(2):183-90. PubMed ID: 8883919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and mechanism of inositol monophosphatase.
    Atack JR; Broughton HB; Pollack SJ
    FEBS Lett; 1995 Mar; 361(1):1-7. PubMed ID: 7890024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereochemistry at phosphorus of the reaction catalyzed by myo-inositol monophosphatase.
    Fauroux CM; Lee M; Cullis PM; Douglas KT; Gore MG; Freeman S
    J Med Chem; 2002 Mar; 45(6):1363-73. PubMed ID: 11882005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels.
    Nemanov L; Ebstein RP; Belmaker RH; Osher Y; Agam G
    Int J Neuropsychopharmacol; 1999 Mar; 2(1):25-29. PubMed ID: 11281967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.